Andrew Volosov serves as Vice President of Clinical Pharmacology and Pharmacokinetics at Galectin Therapeutics, bringing over two decades of experience in the pharmaceutical industry. Holding a PhD from The Hebrew University of Jerusalem, he has deep expertise in drug metabolism, pharmacokinetics, and biomarker development, having held senior roles at Premier Research, Shire, and Sepracor.
He is the co-inventor on multiple patents for novel pharmaceutical compositions and has authored or co-authored numerous peer-reviewed manuscripts and abstracts.
Andrew Volosov
Vice President, Clinical Pharmacology and Preclinical R&D at Galectin Therapeutics
Waban, Massachusetts, United States
Overview
Topics They Care About
Clinical Pharmacology
His career focus for over 20 years, leading clinical pharmacology and preclinical R&D in his current role at Galectin Therapeutics.
Drug Development
Manages the execution of clinical pharmacology strategy, a key component in advancing new drugs through the development pipeline.
Pharmacokinetics (PK/DMPK)
A core area of his expertise, evidenced by his PhD specialization and leadership roles in Drug Metabolism and Pharmacokinetics (DMPK) at multiple companies.
Media Appearances
Andrew has no verified media appearances
Work History
11-2025
Vice President, Clinical Pharmacology and Preclinical R&D at Galectin Therapeutics
6-2023 - 11-2025
Senior Director, Clinical Pharmacology and Preclinical Research & Development at Galectin Therapeutics
5-2023
Senior Director, Clinical Pharmacokinetics at Premier Research
Group Leader, Biomarker Development at Shire HGT
Associate Director, Drug Metabolism and Pharmacokinetics at Sepracor
Director, DMPK at Inotek Pharmaceuticals
Associate Director, DMPK at Inotek Pharmaceuticals
Education
1995 - 2000
PhD from The Hebrew University of Jerusalem
More Information
Social Presence :
Prographics :
Exp : 2
Location : Waban, Massachusetts, United States
Job Level : Senior
Designation : Vice President, Clinical Pharmacology and Preclinical R&D at Galectin Therapeutics
